MedTrace Logo

Mupirocin to Reduce Staphylococcus Aureus Colonization in Infants Hospitalized in a NICU

NCT02967432 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2020-12-21

No results posted yet for this study

Summary

The purpose of this study is to determine whether or not mupirocin treatment results in S. aureus decolonization in affected NICU patients.

Conditions

  • Staphylococcus

Interventions

DRUG

Mupirocin Topical Ointment

Mupirocin ointment 1/2 inch ribbon applied topically to each nare and umbilicus twice daily for 5 days; repeat treatment courses possible.

DRUG

Petroleum Jelly

Petroleum jelly ointment 1/2 inch ribbon applied topically to each nare and umbilicus twice daily for 5 days; repeat treatment courses possible.

Sponsors & Collaborators

  • Jana Shaw, MD

    collaborator UNKNOWN

  • Steven Gross, MD

    collaborator UNKNOWN

  • David Martin, RN

    collaborator UNKNOWN

  • Dale Franz, RPh

    collaborator UNKNOWN

  • Rachel Carey

    collaborator UNKNOWN

  • Crouse Hospital

    lead OTHER

Principal Investigators

  • Melissa U Nelson, MD · Crouse Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02967432 on ClinicalTrials.gov